Caprock Group’s Elanco Animal Health ELAN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.39M Buy
58,133
+5,998
+12% +$147K 0.03% 458
2025
Q4
$1.18M Buy
52,135
+32,634
+167% +$710K 0.02% 562
2025
Q3
$358K Buy
+19,501
New +$327K 0.01% 892
2025
Q1
Sell
-11,637
Closed -$141K 1107
2024
Q4
$141K Sell
11,637
-45,443
-80% -$595K ﹤0.01% 955
2024
Q3
$839K Sell
57,080
-5,851
-9% -$81.5K 0.03% 435
2024
Q2
$908K Sell
62,931
-5
-0% -$80 0.04% 391
2024
Q1
$1.02M Sell
62,936
-15,442
-20% -$241K 0.06% 239
2023
Q4
$1.17M Sell
78,378
-155
-0.2% -$1.76K 0.07% 219
2023
Q3
$883K Buy
78,533
+16
+0% +$186 0.07% 237
2023
Q2
$790K Buy
78,517
+25,759
+49% +$239K 0.06% 261
2023
Q1
$496K Buy
+52,758
New +$622K 0.04% 364
2022
Q4
Sell
-13,200
Closed -$164K 573
2022
Q3
$164K Buy
+13,200
New +$231K 0.02% 531

Other funds holding ELAN

Caprock Group's ELAN Position: Q1 2026 in Review

Caprock Group increased its Elanco Animal Health (ELAN) stake by 12% in Q1 2026, buying an estimated $147K and bringing the position to 58,133 shares worth $1.39M. The position accounts for 0.03% of the portfolio, ranked #458.

Caprock Group first reported a position in ELAN in Q3 2022 and has held it in 12 quarters since. 515 funds tracked by Wall St. Rank hold ELAN as of Q1 2026.

  • Caprock Group held 58,133 shares of Elanco Animal Health worth $1.39M as of Q1 2026.
  • Caprock Group bought 5,998 Elanco Animal Health shares in Q1 2026, an estimated $147K.
  • Elanco Animal Health made up 0.03% of Caprock Group's portfolio in Q1 2026, its #458 holding.
  • Caprock Group first reported a position in Elanco Animal Health in Q3 2022 and has held it in 12 quarters since.
  • 515 funds tracked by Wall St. Rank held Elanco Animal Health as of Q1 2026.

Based on Caprock Group's 13F filing for Q1 2026, filed 11 May 2026.